FIELD: chemistry.
SUBSTANCE: invention refers to new compounds satisfying general formula (I): where: R1 stands for direct or branched (C1-C7)alkyl, X stands for hydrogen atom, R2 stands for the group chosen from naphthalenyl, pyridinyl, isoquinoleinyl, thienyl, imidazolyl, benzothienyl, benzimidazolyl, indolyl, benzotriazolyl and optionally substituted with one or more substitutes chosen from halogen atoms and following groups: (C1-C4)alkyls, thio(C1-C4)alkyls or phenyls, optionally substituted with one or more substitutes chosen from halogen atoms or trifluoromethyl, as free base or additive salt with acid. Additionally, the invention concerns medical product, pharmaceutical composition, and application.
EFFECT: production of new biologically active compounds active to specific inhibitors of glycine glyt 1 and/or glyt 2 carriers.
6 cl, 3 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF N-[PHENYL(PYRROLIDIN-2-YL)METHYL]BENZAMIDE AND N-[(AZEPAN-2-YL)PHENYLMETHYL]BENZAMIDE, METHOD OF OBTAINING SAID COMPOUNDS AND USE THEREOF IN THERAPY | 2004 |
|
RU2386614C2 |
DERIVATIVES OF N-HETEROCYCLYLMETHYLMENZAMIDES, OBTAINMENT AND APPLICATION IN THERAPY | 2004 |
|
RU2346945C2 |
N-[PHENYL(ALKYLPIPERIDINE-2-YL]BENZAMIDE DERIVATIVES, AND THEIR APPLICATION IN THERAPY | 2004 |
|
RU2351589C2 |
N-[HETEROARYL(PIPERIDINE-2-YL)METHYL]BENZAMIDE DERIVATIVES AND APPLICATION IN THERAPY | 2004 |
|
RU2351596C2 |
(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS | 2012 |
|
RU2681211C2 |
BORONIC ACID DERIVATIVES | 2018 |
|
RU2793315C2 |
NOVEL CYCLOPENTANE DERIVATIVES | 2010 |
|
RU2572555C2 |
CYCLOPROPYLAMIDE DERIVATIVES AS N-HISTAMINE RECEPTOR MODULATORS | 2007 |
|
RU2449989C2 |
NEW CONJUGATES BINDING COMPOUND - ACTIVE COMPOUND (ADC) AND USE THEREOF | 2012 |
|
RU2610336C2 |
HYDROXYETHYLAMINOSULFONEAMIDES, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION RETROVIRAL PROTEASES, METHOD OF TREATMENT OF RETROVIRAL INFECTIONS, METHOD OF TREATMENT OF AIDS | 1993 |
|
RU2173680C2 |
Authors
Dates
2009-04-10—Published
2004-10-15—Filed